Supplier’s Conundrum: When Is a Sale Considered “Within the United States” under the U.S. Patent Act? READ MORE
En Banc 9th Circuit Puts Packaged Tuna Antitrust Classes Back in the Case, Dissent Warns of a “Tidal Wave Of Monstrously Oversized Classes” READ MORE
Haug Partners Secures Victory Before the PTAB for MED-EL Elektromedizinische Geräte Ges.m.b.H. READ MORE
FTC’s Pharmaceutical Antitrust Suit Over Opioid License Agreement Between Endo and Impax Dismissed Because Patent Act Permits Exclusive Licenses READ MORE
Timing is Everything: Subsequent Invalidity Ruling Does Not Excuse Violation of an ITC Exclusion Order READ MORE
Federal Circuit Denies Rehearing in Biogen v. Mylan: Dissent Raises Four Written Description “Points of Error” That En Banc Court Should Have Corrected READ MORE
